The price of Levetiracetam (Keppra) can vary depending on factors such as dosage, quantity, pharmacy, and insurance coverage. Levetiracetam is a generic medication, and its cost is generally lower than the brand-name version, Keppra.
What is the cost of generic Levetiracetam?
The price for a 30-day supply of generic Levetiracetam (e.g., 500 mg tablets) can range from approximately \$10 to \$30 without insurance. With prescription drug plans, the out-of-pocket cost is often significantly reduced, sometimes to as little as \$0 to \$10 for the same supply [1]. Prices can fluctuate based on the specific manufacturer and pharmacy.
How does Levetiracetam work for seizure control?
Levetiracetam is an anticonvulsant medication used to treat partial-onset seizures, myoclonic seizures in epilepsy, and generalized tonic-clonic seizures [2]. It is believed to work by binding to the synaptic vesicle protein 2A (SV2A) in the brain, which may modulate neurotransmitter release and inhibit neuronal excitability [3].
When does the patent for Keppra expire?
The original patents for Keppra have expired, allowing for the production and sale of generic versions. Patent expiry dates are crucial for the entry of generic competition, which typically leads to lower drug prices [4].
What are the alternatives to Levetiracetam for epilepsy?
Several other anticonvulsant medications are available for epilepsy treatment, including valproic acid, lamotrigine, phenytoin, and carbamazepine. The choice of medication depends on the type of seizures, a patient's medical history, and potential side effects [2].
Where can I find pricing information for Levetiracetam?
DrugPatentWatch.com provides information on drug patents and market exclusivity, which can influence drug pricing and the availability of generics [4]. Online pharmacies and insurance provider formularies can also offer specific pricing details for Levetiracetam.
---
Sources:
1. GoodRx. (n.d.). Levetiracetam Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/levetiracetam
2. National Institute of Neurological Disorders and Stroke. (n.d.). Epilepsy and Seizures: Hope Through Research. Retrieved from https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures
3. Perucca, E. (2006). Levetiracetam. The Lancet, 368(9533), 473-481.
4. DrugPatentWatch. (n.d.). Levetiracetam Drug Profile. Retrieved from https://drugpatentwatch.com/drug/levetiracetam